Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas

Journal of Dermatological Science

Volumn 42, Issue 2, 2006, Pages 101-109

  Fang, Jia You ^a   Lee, Woan Ruoh ^b,c   Shen, Shing Chuan ^d,e   Huang, Yen Ling ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

( ) Epigallocatechin gallate; Basal cell carcinoma; Intratumor; Liposomes

Indexed keywords

ALCOHOL; ANIONIC SURFACTANT; CATECHIN; CHOLESTEROL; DEOXYCHOLIC ACID; EPICATECHIN; EPIGALLOCATECHIN GALLATE; LIPOSOME; PHOSPHATIDYLCHOLINE; POLYSORBATE 80;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASAL CELL CARCINOMA; CELL VIABILITY; COLON TUMOR; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DEGRADATION; DRUG DISTRIBUTION; DRUG RELEASE; DRUG UPTAKE; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TEA; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; CATECHIN; CELL LINE, TUMOR; DEOXYCHOLIC ACID; DRUG DELIVERY SYSTEMS; ETHANOL; FEMALE; HUMANS; LIPOSOMES; MELANOMA; MICE; MICE, INBRED BALB C; TEA;

EID: 33646491901     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2005.12.010     Document Type: Article

References (30)

1. Katiyar S.K., Ahmad N., and Mukhtar H. Green tea and skin. Arch Dermatol 136 (2000) 989-994
2. Fujiki H., Suganuma M., Imai K., and Nakachi K. Green tea: cancer preventive beverage and/or drug. Cancer Lett 188 (2002) 9-13
3. Wang Z.Y., Huang M.T., Ho C.T., Chang R., Ma W., Ferraro T., et al. Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res 52 (1992) 6657-6665
4. Mukhtar H., Katiyar S.K., and Agarwal R. Green tea-anticarcinogenic effects. J Invest Dermatol 102 (1994) 3-7
5. Levin C., and Maibach H.I. Exploration of alternative and natural drugs in dermatology. Arch Dermatol 138 (2002) 207-211
6. Huang C.C., Fang J.Y., Wu W.B., Chiang H.S., Wei Y.J., and Hung C.F. Protective effects of (-)-epigallocatechin gallate on UVA-induced damage in HaCaT keratinocytes. Arch Dermatol Res 296 (2005) 473-481
7. Suganuma M., Okabe S., Kai Y., Sueoka N., Sueoka E., and Fujiki H. Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer cell line PC-9. Cancer Res 59 (1999) 44-47
8. Dvorakova K., Dorr R.T., Valcic S., Timmermann B., and Alberts D.S. Pharmacokinetics of the green tea derivatives, EGCG, by the topical route of administration in mouse and human skin. Cancer Chemother Pharmacol 43 (1999) 331-335
9. 3H-labelled tea antioxidants (+)-catechin and (-)-epicatechin in rat. Xenobiotica 33 (2003) 743-753
10. Cai Y., Anavy N.D., and Chow H.S.S. Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats. Drug Metab Dispos 30 (2002) 1246-1249
11. Kawakami S., Yamashita F., and Hashida M. Disposition characteristics of emulsions and incorporated drugs after systemic or local injection. Adv Drug Deliv Rev 45 (2000) 77-88
12. Soleas G.J., Grass L., Josephy P.D., Goldberg D.M., and Diamandis E.P. A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin Biochem 35 (2002) 119-124
13. Thissen M.R.T.M., Neumann M.H.A., and Schouten L.J. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 135 (1999) 1177-1183
14. Chiang L.C., Chiang W., Yu H.S., Sheu H.M., and Chen H.Y. Establishment and characterization of a continuous human basal cell carcinoma cell line from facial skin (I) cytological behavior of early passages. Kaohsiung J Med Sci 10 (1994) 170-176
15. Yen H.T., Chiang L.C., Wen K.H., Tsai C.C., Yu C.L., and Yu H.S. The expression of cytokines by an established basal cell carcinoma cell line (BCC-1/KMC) compared with cultured normal keratinocytes. Arch Dermatol Res 288 (1996) 157-161
16. Fang J.Y., Hung C.F., Hwang T.L., and Huang Y.L. Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations. J Drug Target 13 (2005) 19-27
17. ®. Eur J Pharm Biopharm 49 (2000) 143-149
18. Dayan N., and Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21 (2000) 1879-1885
19. Godin B., and Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Contr Rel 94 (2004) 365-379
20. Hashimoto T., Kumazawa S., Nanjo F., Hara Y., and Nakayama T. Interaction of tea catechins with lipid bilayers investigated with liposome systems. Biosci Biotechnol Biochem 63 (1999) 2252-2255
21. Yamaguchi T. Lipid microspheres as drug carriers: a pharmaceutical point of view. Adv Drug Deliv Rev 20 (1996) 117-130
22. Mizuguchi H., Nakanishi T., Nakanishi M., Nakagawa T., Nakagawa S., and Mayumi T. Intratumor administration of fusogenic liposomes containing fragment A of diphtheria toxin suppresses tumor growth. Cancer Lett 100 (1996) 63-69
23. Nagayasu A., Uchiyama K., and Kiwada H. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv Drug Deliv Rev 40 (1999) 75-87
24. El Maghraby G.M.M., Williams A.C., and Barry B.W. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J Pharm Pharmacol 53 (2001) 1069-1077
25. Suzuki Y., and Isemura M. Inhibitory effect of epigallocatechin gallate on adhesion of murine melanoma cells to laminin. Cancer Lett 173 (2001) 15-20
26. McLoughlin P., Roengvoraphoj M., Cornelia Q., Hescheler J., Certa U., and Sachinidis A. Transcriptional responses to epigallocatechin-3 gallate in HT 29 colon carcinoma spheroids. Genes Cells 9 (2004) 661-669
27. Harasym T.O., Cullis P.R., and Bally M.B. Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes. Cancer Chemother Pharmacol 40 (1997) 309-317
28. Arashiro K. The tumor vasculature in cutaneous malignant melanoma: scanning electron microscopy of corrosion casts. Plast Reconstr Surg 110 (2002) 717-718
29. Marzola P., Degrassi A., Calderan L., Farace P., Crescimanno C., Nicolato E., et al. In vivo assessment of antiangiogenic activity of SU6668 in an experimental colon carcinoma model. Clin Cancer Res 10 (2004) 739-750
30. Videla L.A. Assessment of the scavenging action of reduced glutathione, (+)cyanidanol-3 and ethanol by the chemiluminescent response of the xanthine oxidase reaction. Experientia 39 (1983) 500-502